SCHEMBL5367586

SCHEMBL5367586

CC(C)c1ccc(Cl)c(Cl)c1.[AsH2]c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.45
TDO2 P48775 1/20 0.45
IDO2 Q6ZQW0 1/20 0.45
SLC6A4 P31645 10/20 0.42
SLC6A2 P23975 9/20 0.42
SLC6A3 Q01959 9/20 0.42
KCNH2 Q12809 4/20 0.42
CYP3A4 P08684 4/20 0.42
CYP2D6 P10635 4/20 0.42
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL10347735 0.84 ALDH1A1 (0.49) IDO1TDO2IDO2SLC6A4SLC6A2
SCHEMBL254524 0.84 AHR (0.50) IDO1TDO2IDO2SLC6A4SLC6A2
SCHEMBL12204112 0.75 IDO1 (0.53) IDO1TDO2IDO2SLC6A4SLC6A2
SCHEMBL13524616 0.72 AHR (0.54) CYP3A4ALDH1A1HTTSMN1; SMN2CYP1A2
SCHEMBL13524519 0.72 CYP2A6 (0.48) LMNACYP1A2CYP2C9CYP2C19MEN1
SCHEMBL14670465 0.71 AHR (0.67) SLC6A4SLC6A2SLC6A3CYP1A2CYP2C9
SCHEMBL4780127 0.71 AHR (0.46) IDO1TDO2IDO2SLC6A4SLC6A2
Isopropylbenzene SCHEMBL7041369 0.70 TAAR1 (0.48) CYP2D6LMNAHTTCYP2C9
Benzene SCHEMBL5833599 0.69 TYR (0.52) IDO1CYP2D6ALDH1A1LMNAHTT
SCHEMBL5311100 0.69 IDO1 (0.51) IDO1TDO2IDO2SLC6A4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007017652-A2 ARYLAKYLAMINES FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2007-02-15 WO claimed
WO-2007017652-A2 ARYLAKYLAMINES FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2007-02-15 WO disclosed